Reduction of hyperacute rejection and protection of metabolism and function in hearts of human decay accelerating factor (hDAF)-expressing pigs

Cardiovascular Research

Volumn 73, Issue 1, 2007, Pages 143-152

  Smolenski, Ryszard T ^a,d   Forni, Monica ^b   Maccherini, Massimo ^c   Bacci, Maria Laura ^b   Slominska, Ewa M ^d   Wang, Hongjun ^e   Fornasari, PierMaria ^f   Giovannoni, Roberto ^e   Simeone, Felicetta ^c   Zannoni, Augusta ^b   Frati, Giacomo ^g   Suzuki, Ken ^a   Yacoub, Magdi H ^a   Lavitrano, Marialuisa ^e  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cardiac function; Hyperacute rejection; SMGT; Transgenic pigs; Xenotransplantation

Indexed keywords

DECAY ACCELERATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EVALUATION; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART OUTPUT; HEART PERFUSION; NONHUMAN; PRIORITY JOURNAL; SWINE; TRANSGENIC ANIMAL;

ACUTE DISEASE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; BREEDING; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INSEMINATION, ARTIFICIAL; MALE; MODELS, ANIMAL; MYOCARDIUM; PERFUSION; SPERMATOZOA; SWINE; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 33845589973     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.10.027     Document Type: Article

References (35)

1. Bach F.H. Xenotransplantation: problems and prospects. Annu Rev Med 49 (1998) 301-310
2. Cooper D.K., Gollackner B., and Sachs D.H. Will the pig solve the transplantation backlog?. Annu Rev Med 53 (2002) 133-147
3. Appel III J.Z., Buhler L., and Cooper D.K. The pig as a source of cardiac xenografts. J Card Surg 16 (2001) 345-356
4. Tucker A., Belcher C., Moloo B., Bell J., Mazzulli T., Humar A., et al. The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 9 (2002) 191-202
5. Bach F.H., Winkler H., Ferran C., Hancock W.W., and Robson S.C. Delayed xenograft rejection. Immunol Today 17 (1996) 379-384
6. Itescu S., Kwiatkowski P., Artrip J.H., Wang S.F., Ankersmit J., Minanov O.P., et al. Role of natural killer cells, macrophages, and accessory molecule interactions in the rejection of pig-to-primate xenografts beyond the hyperacute period. Hum Immunol 59 (1998) 275-286
7. Platt J.L. The immunological hurdles to cardiac xenotransplantation. J Card Surg 16 (2001) 439-447
8. Robson S.C., Schulte am Esch II J., and Bach F.H. Factors in xenograft rejection. Ann N Y Acad Sci 875 (1999) 261-276
9. Dalmasso A.P., Vercellotti G.M., Platt J.L., and Bach F.H. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 52 (1991) 530-533
10. Kolber-Simonds D., Lai L., Watt S.R., Denaro M., Arn S., Augenstein M.L., et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 101 (2004) 7335-7340
11. Schmoeckel M., Nollert G., Shahmohammadi M., Young V.K., Chavez G., Kasper-Konig W., et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 62 (1996) 729-734
12. Vial C.M., Ostlie D.J., Bhatti F.N., Cozzi E., Goddard M., Chavez G.P., et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 19 (2000) 224-229
13. Archer K., and McLellan F. Controversy surrounds proposed xenotransplant trial. Lancet 359 (2002) 949
14. Kaiser J. Xenotransplantation. Cloned pigs may help overcome rejection. Science 295 (2002) 25-27
15. Lai L., Kolber-Simonds D., Park K.W., Cheong H.T., Greenstein J.L., Im G.S., et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295 (2002) 1089-1092
16. Dai Y., Vaught T.D., Boone J., Chen S.H., Phelps C.J., Ball S., et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20 (2002) 251-255
17. Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 299 (2003) 411-414
18. Kuwaki K., Tseng Y.L., Dor F.J., Shimizu A., Houser S.L., Sanderson T.M., et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 11 (2005) 29-31
19. Yamada K., Yazawa K., Shimizu A., Iwanaga T., Hisashi Y., Nuhn M., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32-34
20. Cooper D.K. Clinical xenotransplantion-how close are we?. Lancet 362 (2003) 557-559
21. Webster N.L., Forni M., Bacci M.L., Giovannoni R., Razzini R., Fantinati P., et al. Multi-transgenic pigs expressing three fluorescent proteins produced with high efficiency by sperm mediated gene transfer. Mol Reprod Dev 72 (2005) 68-76
22. Lavitrano M., Camaioni A., Fazio V.M., Dolci S., Farace M.G., and Spadafora C. Sperm cells as vectors for introducing foreign DNA into eggs: genetic transformation of mice. Cell 57 (1989) 717-723
23. Lavitrano M., Forni M., Bacci M.L., Di Stefano C., Varzi V., Wang H., et al. Sperm mediated gene transfer in pig: selection of donor boars and optimization of DNA uptake. Mol Reprod Dev 64 (2003) 284-291
24. Lavitrano M., Bacci M.L., Forni M., Lazzereschi D., Di Stefano C., Fioretti D., et al. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. Proc Natl Acad Sci U S A 99 (2002) 14230-14235
25. Smolenski R.T., Raisky O., Slominska E.M., Abunasra H., Kalsi K.K., Jayakumar J., et al. Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation 104 (2001) I246-I252
26. Smolenski R.T., Kalsi K.K., Zych M., Kochan Z., and Yacoub M.H. Adenine/ribose supply increases adenosine production and protects ATP pool in adenosine kinase-inhibited cardiac cells. J Mol Cell Cardiol 30 (1998) 673-683
27. Smolenski R.T., Lachno D.R., Ledingham S.J., and Yacoub M.H. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 527 (1990) 414-420
28. Smolenski R.T., and Yacoub M.H. Liquid chromatographic evaluation of purine production in the donor human heart during transplantation. Biomed Chromatogr 7 (1993) 189-195
29. Manji R.A., Manji J.S., Koshal A., Korbutt G.S., and Rajotte R.V. Human ABO blood group is important in survival and function of porcine working hearts. Am J Transplant 3 (2003) 286-293
30. Khalpey Z., Yuen A.H., Kalsi K.K., Kochan Z., Karbowska J., Slominska E.M., et al. Loss of ecto-5′nucleotidase from porcine endothelial cells after exposure to human blood: implications for xenotransplantation. Biochim Biophys Acta 1741 (2005) 191-198
31. Waterworth P.D., Dunning J., Tolan M., Cozzi E., Langford G., Chavez G., et al. Life-supporting pig-to-baboon heart xenotransplantation. J Heart Lung Transplant 17 (1998) 1201-1207
32. Forty J., White D.G., and Wallwork J. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection. J Thorac Cardiovasc Surg 106 (1993) 308-316
33. Suckfull M., Mudsam M., Pieske O., Enders G., Babic R., and Hammer C. Immunohistological studies of complement activation after xenogeneic perfusion of a working heart model. Transpl Int 7 (1994) 324-328
34. Brenner P., Hinz M., Huber H., Schmoeckel M., Reichenspurner H., Meiser B., et al. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model. Eur J Cardiothorac Surg 15 (1999) 672-679
35. Liu J.S., John G.R., Sikora A., Lee S.C., and Brosnan C.F. Modulation of interleukin-1beta and tumor necrosis factor alpha signaling by P2 purinergic receptors in human fetal astrocytes. J Neurosci 20 (2000) 5292-5299